INS and medulloblastoma: Furthermore, prioritization of insulin signaling as a therapeutic target in medulloblastoma has been proposed by Wu et al. Their recent studies suggest a bicompartmental model of leptomeningeal metastasis whereby restricted metastatic clones arise via clonal selection of the primary tumor and that PI3 kinase signaling contributes to medulloblastoma progression and metastasis (29).